End-of-day quote
Taipei Exchange
18:00:00 2024-05-13 EDT
|
5-day change
|
1st Jan Change
|
75.1
TWD
|
+4.31%
|
|
+2.32%
|
-13.78%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
5,781
|
5,227
|
5,032
|
11,810
|
7,334
|
6,531
|
Enterprise Value (EV)
1 |
6,068
|
5,309
|
4,948
|
12,221
|
7,698
|
6,719
|
P/E ratio
|
23.7
x
|
23.9
x
|
40.9
x
|
32.7
x
|
19.3
x
|
-264
x
|
Yield
|
3.63%
|
3.5%
|
2.07%
|
2.41%
|
4.7%
|
-
|
Capitalization / Revenue
|
1.18
x
|
1.58
x
|
2.25
x
|
2.86
x
|
1.39
x
|
2.82
x
|
EV / Revenue
|
1.23
x
|
1.6
x
|
2.21
x
|
2.96
x
|
1.46
x
|
2.9
x
|
EV / EBITDA
|
24.8
x
|
20.8
x
|
28.4
x
|
27.9
x
|
20
x
|
48.4
x
|
EV / FCF
|
17.7
x
|
15.7
x
|
16.4
x
|
-26.8
x
|
52.9
x
|
12.9
x
|
FCF Yield
|
5.65%
|
6.36%
|
6.08%
|
-3.73%
|
1.89%
|
7.76%
|
Price to Book
|
4.68
x
|
4.25
x
|
4.32
x
|
8.55
x
|
4.89
x
|
5.82
x
|
Nbr of stocks (in thousands)
|
74,986
|
74,986
|
74,986
|
74,986
|
74,986
|
74,986
|
Reference price
2 |
77.10
|
69.70
|
67.10
|
157.5
|
97.80
|
87.10
|
Announcement Date
|
19-03-29
|
20-03-31
|
21-03-25
|
22-03-22
|
23-03-30
|
24-03-15
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
4,917
|
3,315
|
2,235
|
4,126
|
5,271
|
2,316
|
EBITDA
1 |
244.7
|
255.8
|
174
|
437.9
|
384.2
|
139
|
EBIT
1 |
216.7
|
231.7
|
151.4
|
417.1
|
362
|
115.1
|
Operating Margin
|
4.41%
|
6.99%
|
6.78%
|
10.11%
|
6.87%
|
4.97%
|
Earnings before Tax (EBT)
1 |
300.7
|
277.4
|
161.1
|
460.3
|
481.3
|
4.937
|
Net income
1 |
244.1
|
218.9
|
123.3
|
360.6
|
381.3
|
-24.54
|
Net margin
|
4.97%
|
6.6%
|
5.52%
|
8.74%
|
7.23%
|
-1.06%
|
EPS
2 |
3.250
|
2.919
|
1.640
|
4.809
|
5.080
|
-0.3300
|
Free Cash Flow
1 |
342.7
|
337.5
|
300.9
|
-455.5
|
145.4
|
521.3
|
FCF margin
|
6.97%
|
10.18%
|
13.46%
|
-11.04%
|
2.76%
|
22.5%
|
FCF Conversion (EBITDA)
|
140.05%
|
131.95%
|
172.9%
|
-
|
37.85%
|
375.15%
|
FCF Conversion (Net income)
|
140.37%
|
154.19%
|
244.09%
|
-
|
38.13%
|
-
|
Dividend per Share
2 |
2.800
|
2.440
|
1.390
|
3.800
|
4.600
|
-
|
Announcement Date
|
19-03-29
|
20-03-31
|
21-03-25
|
22-03-22
|
23-03-30
|
24-03-15
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
287
|
82.7
|
-
|
410
|
365
|
188
|
Net Cash position
1 |
-
|
-
|
83.6
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.172
x
|
0.3232
x
|
-
|
0.9369
x
|
0.9495
x
|
1.354
x
|
Free Cash Flow
1 |
343
|
337
|
301
|
-456
|
145
|
521
|
ROE (net income / shareholders' equity)
|
20.2%
|
17.7%
|
10.3%
|
28.3%
|
26.5%
|
-1.87%
|
ROA (Net income/ Total Assets)
|
5.91%
|
6.75%
|
5.29%
|
13%
|
9.14%
|
3.47%
|
Assets
1 |
4,132
|
3,243
|
2,331
|
2,782
|
4,170
|
-708.1
|
Book Value Per Share
2 |
16.50
|
16.40
|
15.50
|
18.40
|
20.00
|
15.00
|
Cash Flow per Share
2 |
6.880
|
6.210
|
3.420
|
5.770
|
4.890
|
2.430
|
Capex
1 |
10.6
|
10.9
|
15.3
|
34.5
|
47.3
|
45
|
Capex / Sales
|
0.21%
|
0.33%
|
0.69%
|
0.84%
|
0.9%
|
1.94%
|
Announcement Date
|
19-03-29
|
20-03-31
|
21-03-25
|
22-03-22
|
23-03-30
|
24-03-15
|
|
1st Jan change
|
Capi.
|
---|
| -13.78% | 167M | | +16.91% | 66.18B | | +1.64% | 49.24B | | +16.70% | 41.72B | | +22.44% | 26.16B | | +12.92% | 19.75B | | +2.79% | 17.5B | | -23.54% | 15.63B | | -6.24% | 15.46B | | +2.52% | 15.43B |
Other Specialty Chemicals
|